AG
IMGN

Aperio Group’s Immunogen Inc IMGN Stock Holding History

Aperio Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$210K Sell
32,609
-2,019
-6% -$11.8K ﹤0.01% 2297
2020
Q3 		$125K Buy
34,628
+668
+2% +$2.7K ﹤0.01% 2299
2020
Q2 		$156K Buy
33,960
+3,261
+11% +$13.9K ﹤0.01% 2222
2020
Q1 		$105K Buy
30,699
+10,381
+51% +$45.4K ﹤0.01% 2214
2019
Q4 		$104K Buy
20,318
+2,810
+16% +$9.54K ﹤0.01% 2261
2019
Q3 		$42K Buy
17,508
+11,288
+181% +$30K ﹤0.01% 2285
2019
Q2 		$13K Sell
6,220
-4,172
-40% -$9.87K ﹤0.01% 2754
2019
Q1 		$28K Sell
10,392
-2,975
-22% -$12.9K ﹤0.01% 2277
2018
Q4 		$64K Buy
13,367
+981
+8% +$5.95K ﹤0.01% 2254
2018
Q3 		$117K Buy
+12,386
New +$119K ﹤0.01% 2242
2017
Q3 		– Sell
-16,797
Closed -$119K – 2244
2017
Q2 		$119K Buy
16,797
+5,221
+45% +$23.9K ﹤0.01% 2168
2017
Q1 		$45K Buy
+11,576
New +$33.8K ﹤0.01% 2133
2014
Q4 		– Sell
-16,077
Closed -$170K – 1919
2014
Q3 		$170K Buy
+16,077
New +$182K ﹤0.01% 1638

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aperio Group's IMGN Position: Q4 2020 in Review

Aperio Group reduced its Immunogen Inc (IMGN) stake by 5.8% in Q4 2020, selling an estimated $11.8K and leaving 32,609 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #2297.

Aperio Group first reported a position in IMGN in Q3 2014 and has held it in 13 quarters since. 211 funds tracked by Wall St. Rank hold IMGN as of Q4 2020.

  • Aperio Group held 32,609 shares of Immunogen Inc worth $210K as of Q4 2020.
  • Aperio Group sold 2,019 Immunogen Inc shares in Q4 2020, an estimated $11.8K.
  • Immunogen Inc made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2297 holding.
  • Aperio Group first reported a position in Immunogen Inc in Q3 2014 and has held it in 13 quarters since.
  • 211 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.